Search
for
Sort by
Research 31–60 of 1000+
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- O que sabemos sobre os inibidores da 5 alfa redutase?
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Adverse effects of common medications on male fertility
- Steroid Hormones
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- Hair: What is New in Diagnosis and Management?
- Hormone therapy in acne
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Androgenetic Alopecia Treated With Topical Minoxidil. A Case Report and Review of Treatment Options
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Idiopathic Hirsutism*
- Androgenetic alopecia; drug safety and therapeutic strategies
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- 5α-Reductases in Human Physiology: An Unfolding Story
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?